Fibromyalgia Trial, Recruiting NCT07555691 Sponsor: Juan Jiao Condition: Fibromyalgia
Back to Fibromyalgia

Fibromyalgia Trial, Recruiting

NCT07555691
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with primary fibromyalgia according to the 2016 criteria set by the American College of Rheumatology
  • People whose fibromyalgia fits certain Traditional Chinese Medicine (TCM) patterns related to liver and kidney energy imbalances (confirm with trial site)
  • People aged 18 to 75 years old
  • People whose pain rates 4 or higher on a 0–10 pain scale
  • People who have not been taking any fibromyalgia medications or following a fibromyalgia treatment programme for more than one month
  • People who are willing to sign a consent form agreeing to take part

Who may not be able to join:

  • People with severe depression or anxiety
  • People with serious heart, brain, liver, kidney, or blood system conditions, or clotting/thrombotic diseases
  • People who are pregnant or breastfeeding
  • People with known allergies to the treatment ingredients used in the trial
  • People whose severe pain is caused by another condition, such as diabetic nerve pain or post-shingles nerve pain
  • People who have recently taken part in another clinical trial for the same condition
  • People who are male, right-handed, or have any medical reasons that make MRI scanning unsafe — this group will not have MRI scans as part of the trial. Reasons that may make MRI unsafe include: a history of brain tumours, stroke, epilepsy, head injury, or multiple sclerosis; certain implanted devices such as pacemakers, defibrillators, cochlear implants, or nerve stimulators; metal objects in the body such as dentures, metal fragments near the eyes, or shrapnel in certain areas; or claustrophobia (fear of enclosed spaces)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 010-88001132

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Juan Jiao
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
31 October 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The change of the Brief Pain Inventory (BPI) from baseline.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov